Kraig Biocraft Laboratories Inc. is a biotechnology development company focused on genetically engineered high performance polymers and technical fibers. The company is currently working on research to genetically coax silkworms into producing spider silk.

Kraig Biocraft believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications. The overall marketplace for these types of fibers in general is approximated to be $90 billion. According to Emerging Growth Research, an independent industry research firm, if Kraig Biocraft is successful is achieving its goal and producing a spider silk fiber product, “the technology will likely immediately be worth at least several hundred million dollars.”

In order to reach its goal, Kraig Biocraft has leveraged its efforts by working cooperatively with select university laboratories. This arrangement allows the company to bring technologies from diverse research institutions and combine them.

As part of this strategy, Kraig Biocraft licenses university intellectual properties in genetics and genetic engineering, thus allowing them to tap some of the greatest minds in the field. To date, the company has licensed technology from the University of Wyoming and the University of Notre Dame.

The genetic technology involved is very complex. In order to have silkworms produce spider silk, scientists had to develop the technology to successfully insert into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk.

Since the company first obtained the right to use the spider silk gene sequence from the University of Wyoming, Kraig Biocraft has surprised many with the speed of the advances they’ve made. Kraig Biocraft now performs thousands of ‘insertions’ in a single week. This work is occurring at the company’s research program at the University of Notre Dame where substantial progress is being made in the successful insertion of DNA packets, both with the number and proportion of insertions.

As Kraig Biocraft’s success with insertions increases, so does the company’s chance of developing a viable multi-million dollar product.

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board